ArticleFrontiers in oncology2021

MRI T1 Contrast-Enhanced Signal Intensity Is a Prognostic Indicator of Imatinib Therapy in Desmoid-Type Fibromatosis.

Hui Ci Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.